268 related articles for article (PubMed ID: 24837774)
1. Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection.
Pyo HM; Zhou Y
Vaccine; 2014 Jun; 32(30):3835-42. PubMed ID: 24837774
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
[TBL] [Abstract][Full Text] [Related]
3. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
[TBL] [Abstract][Full Text] [Related]
5. Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs.
Pyo HM; Hlasny M; Zhou Y
Vaccine; 2015 Jul; 33(31):3667-72. PubMed ID: 26092308
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA
Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442
[TBL] [Abstract][Full Text] [Related]
7. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
Lee JH; Gramer MR; Joo HS
Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
[TBL] [Abstract][Full Text] [Related]
10. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
[TBL] [Abstract][Full Text] [Related]
11. Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses.
Van Reeth K; Labarque G; Pensaert M
Viral Immunol; 2006; 19(3):373-82. PubMed ID: 16987057
[TBL] [Abstract][Full Text] [Related]
12. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406
[TBL] [Abstract][Full Text] [Related]
13. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
Wesley RD; Lager KM
Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
[TBL] [Abstract][Full Text] [Related]
14. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine.
Babiuk S; Masic A; Graham J; Neufeld J; van der Loop M; Copps J; Berhane Y; Pasick J; Potter A; Babiuk LA; Weingartl H; Zhou Y
Vaccine; 2011 Apr; 29(17):3118-23. PubMed ID: 21382482
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
[TBL] [Abstract][Full Text] [Related]
16. A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
Landreth S; Detmer S; Gerdts V; Zhou Y
Vet Microbiol; 2021 Feb; 253():108968. PubMed ID: 33418392
[TBL] [Abstract][Full Text] [Related]
17. Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs.
Xu J; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Chen W; Lu C
Vet Microbiol; 2013 Feb; 162(1):259-64. PubMed ID: 23265244
[TBL] [Abstract][Full Text] [Related]
18. An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.
Masic A; Pyo HM; Babiuk S; Zhou Y
J Virol; 2013 Sep; 87(18):10114-25. PubMed ID: 23843633
[TBL] [Abstract][Full Text] [Related]
19. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.
Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
Vaccine; 2012 Apr; 30(20):3119-25. PubMed ID: 22391400
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME
Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
